Asthma
Conditions
Keywords
Anxiety, Stress, Asthma
Brief summary
This is a study to develop a protocol on Cognitive behavior therapy (CBT) for asthma-related anxiety that in a consecutive study can be translated to internet-delivered CBT.
Detailed description
Asthma is one of the most common chronic diseases around the world, with a high prevalence of anxiety disorders. Cognitive behaviour therapy (CBT) has been shown to increase psychological well-being for anxiety-related asthma. Our primary aim is to develop a standardized CBT protocol for asthma-related anxiety that can be transferred to internet-delivered CBT. Ten participants will be included in a single-subject multiple baseline design. They will all receive 10-12 sessions of CBT.
Interventions
BEHAVIORALCBT for anxiety-related asthma
The specific assignments in the intervention will be based on individual behavior analysis for each participant.
Sponsors
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Single-subject multiple baseline design.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* asthma diagnosed by a physician * anxiety or stress related to asthma
Exclusion criteria
* severe psychiatric disorder (e.g. psychotic disorder, addiction disorder, suicidal ideation).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Penn State Worry Questionnaire | Baseline to 12 weeks | Change in subjective worry measured with a self-rating scale weekly during 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Short Health Anxiety Inventory (SHAI) | Baseline to 12 weeks | Change in health anxiety measured with a self-rating scale weekly during 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
| Asthma Quality of Life Questionnaire | Baseline to 12 weeks | Change in asthma-related quality of life measured with a self-rating scale at pretreatment and at 10 to 12 weeks post treatment for analysis of effect. |
| Asthma control test | Baseline to 12 weeks | Change in asthma control measured with a self-rating scale daily during weekly 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
| Anxiety Sensitivity Index-3 | Baseline to 12 weeks | Change in anxiety sensitivity measured with a self-rating scale weekly during 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
| Perceived Stress Scale | Baseline to 12 weeks | Change in perceived stress measured with a self-rating scale weekly 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
| Patient Health Questionnaire | Baseline to 12 weeks | Change in depression measured with a self-rating scale at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
| Catastrophizing about asthma Scale | Baseline to 12 weeks | Change in catastrophizing cognitions about asthma measured with a self-rating scale weekly during 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect. |
Countries
Sweden
Outcome results
None listed